Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Congress Passes Sunscreen Bill

by Britt E. Erickson
November 24, 2014 | A version of this story appeared in Volume 92, Issue 47

[+]Enlarge
Credit: Shutterstock
An adult’s hand rubbing sunscreen on the back of a child in a red and white hat.
Credit: Shutterstock

Americans will soon have more choices when it comes to protecting their skin from the sun’s harmful rays thanks to the Sunscreen Innovation Act (S. 2141). The bill, which aims to accelerate FDA’s approval of new sunscreen active ingredients, was passed by the House of Representatives on Nov. 13 and sent to President Barack Obama to sign into law. The legislation cleared the Senate in September. Under the bill, FDA would have to complete a review of the safety and efficacy of a new ingredient and make a regulatory decision within 300 days after an application is filed. The agency would have a shorter deadline for clearing up the current backlog of submissions. Sunscreen manufacturers have long been seeking such a law, claiming that some ingredients awaiting approval in the U.S. have been widely available in Europe and other parts of the world, in some cases for more than a decade. The Public Access to SunScreens Coalition, a group of sunscreen manufacturers and skin cancer experts, says the measure will ensure that FDA approves the latest sunscreens in a predictable time frame.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.